INSIGHTS ON CLINICAL TRIAL TECHNOLOGIES

• How Strategic LQPPV Outsourcing Future-Proofs PV Compliance In The AI Era

  As health authorities seek standardization across global processes and strong AI governance, working with an experienced PV partner will help minimize the burden of oversight and ensure compliance.

• AI And Multi-Omics For Translational Research

  Explore the innovations driving drug discovery breakthroughs and shaping future-ready strategies.

• 4 New Approvals In Q3 Across Gene, Cell, RNA Therapies

  Q3 2025 brought notable progress across the gene, cell, and RNA therapy landscape, marked by four new global approvals. While regulatory progress continued, clinical development activity slowed.

• Building Patient-Centric Cardiovascular Endpoints With Continuous Digital Measures

  Cardiovascular trial teams learn how wearable sensors can strengthen activity and heart health measures while easing patient burden.

• UK Clinical Trial Regulations Reform

  7/24/2026

  UK trial regulations have been overhauled. Learn what faster approval pathways, stricter publication rules, and longer retention requirements mean for your operations.

• Drive Innovation In Clinical Trial Software: 3 Trends You Need To Watch

  7/31/2025

  The clinical trial landscape is undergoing a transformative shift as technology increasingly shapes study design and execution. Explore three pivotal trends that are driving this evolution.

• Reinventing Prostate Cancer Diagnostics With An All-In-One Platform

  3/31/2026

  Discover how a lean research team saved an estimated $100k and reached 95% data compliance by unifying their clinical workflow.

• Accelerating Parkinson's Disease Clinical Research Through Recruitment Capabilities

  1/14/2026

  Centralized PD trials cut variability, speed enrollment, and enable genetic stratification, delivering high‑quality data and faster progress from early‑phase research to late‑stage development.

• How Pfizer Used Wearable DHTs To Reveal Meaningful Treatment Effects In Cancer Cachexia

  11/20/2024

  Wearable digital health technologies (DHTs) played a crucial role in assessing patient-centric outcomes during pfizer's study into the benefits of using ponsegromab for treating cancer cachexia.